Skip to content

Clinical trials

Phase 1 Parkinson Disease trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 1 Country / region: United Kingdom Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20091
20114
20151
20161
20171
20181
20194
20202
20212
20223
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting2
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bial - Portela C S.A.5
MODAG GmbH3
UCB Biopharma SRL2
AstraZeneca1
Bial R&D Investments, S.A.1
Biogen1
GlaxoSmithKline1
Hoffmann-La Roche1
Ionis Pharmaceuticals, Inc.1
Mission Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease25
Alzheimer Disease3
Multiple System Atrophy3
Neurodegenerative Diseases3
Tauopathies3
Lymphoma, Follicular1
Movement Disorders1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.